The Zhitong Finance App learned that the first Traditional Chinese Medicine Ecological Conference and Traditional Chinese Medicine Industry Expo was grandly opened on December 16 in Shenzhen, Guangdong. With the theme of “Linking the whole industry chain and promoting high-quality development”, the conference is an ecological conference focusing on medical development, traditional Chinese medicine innovation, brand display, cultural exchange, technical exchange, physical development, education and training, and commodity trading to comprehensively open up the entire traditional Chinese medicine industry chain.

The conference brought together government agencies, academicians of traditional Chinese medicine, Chinese medicine masters, famous traditional Chinese medicine doctors from all over the country, directors of traditional Chinese medicine hospitals, leading traditional Chinese medicine companies, Chinese herbal medicine planting bases, Chinese medicine centers, etc., 100+ large traditional Chinese medicine manufacturers (finished medicines, formula, tablets), 200+ authentic herbal medicine planting bases, TOP300 chains and traditional Chinese medicine specialty chains, 1,200+ traditional Chinese medicine clinics and medical chains, more than 1,000 traditional Chinese medicine health care institutions, and 100+ technology companies. Through a combination of conferences and exhibitions, the conference achieved coverage, linkage and interaction of the entire “government, industry, academia, research, use, and capital” industry chain, helping enterprises reduce costs and increase efficiency in multiple dimensions.

According to the data forecast of Zhongkang Technology, in 2023, the market size of the national traditional Chinese medicine industry reached 1.93 trillion yuan, an increase of 8.3% over the previous year, and is expected to reach 2.2 trillion yuan in 2025, with a compound increase of 6.8%. Among them, the market size of the Chinese medicine industry, including the cultivation of Chinese herbal medicines, the processing of Chinese medicine tablets and the production of proprietary Chinese medicines, will reach 1.05 trillion yuan in 2023, accounting for 54.4%, and is expected to reach 1.23 trillion yuan in 2025, with a compound growth of 8.2%; the TCM medical services industry will have a market size of 855 billion yuan in 2023, accounting for 44%, and is expected to reach 925 billion yuan in 2025, with a compound growth of 4%.

During this ecological conference, the Zhongkang Yunlin Traditional Chinese Medicine Industry Big Data Center under Zhongkang Holdings (02361) will hold the “2024 Chinese Herbal Medicine Market Forecast Conference” on the afternoon of December 17. It will release a number of digital intelligence prediction results for the first time, and lead a team of top experts to interpret the overall market trends of Chinese herbal medicines in the next 3 years and future market trends of major hot varieties to help industrial enterprises achieve “cost reduction and efficiency” and explore new growth points under the guidance of digital intelligence.

It is worth mentioning that the Zhongkang Yunling Chinese Medicine Industry Big Data Center has established the Zhongkang Yunlin Expert Think Tank, composed of nearly 100 industry and variety think tank experts from around the country. At this conference, participating experts will also discuss with participants how upstream production bases in the Chinese medicine industry chain can collaborate with midstream manufacturers and downstream consumer markets to guide scientific decision-making in the industry, accelerate production and marketing, and promote the high-quality development of the traditional Chinese medicine industry.

Zhongkang Technology, the main business platform of Zhongkang Holdings (02361), has the three core competencies of an extensive data collection network, leading big data processing technology and an ecological health industry platform. By providing “SaaS+ professional services” driven by big data, it has built a “vertical cloud platform for the health industry” around the six major fields of pharmaceutical retail, pharmaceutical industry, medical examination institutions, hospitals, clinics, and commercial insurance, creating a data-driven product portfolio that matches the full life cycle management in vertical fields to help customers make efficient decisions and improve accurate connectivity capabilities.

Meanwhile, the extensive application of Zhongkang Yunlin's big data platform has improved health industry chain data, and witnessed the deepening of the layout of Zhongkang Holdings in the health industry in China. Its data resources and segmentation are more complete, and the linked industrial ecological resources are richer. It has helped the health industry digitally and intelligently transform and upgrade in all aspects, empowering the health industry to improve efficiency.